Microvision, Inc. (NASDAQ:MVIS) shares plummeted 24.08 percent Friday, closing at $2.27, following the firm’s announcement on the same day that its stock offering would comprise 4.2 million shares at $2.50. The offering should yield net proceeds of $9.9 million excluding underwriter fees, and in intended to increase the company’s diluted share count by nearly 25 percent; they have traded in a 52-week range of between $1.11 and $11.04.
II-VI Incorporated (NASDAQ:IIVI) shares closed Friday at $16.25, which represents a slide of 12.63 percent, having been traded in a 52-week range of $15.80 to $28.39.
Dyax Corp. (NASDAQ:DYAX) shares closed down 8.41 percent Friday, which Leerink sees as a buying opportunity, keeping its Outperform. The analyst interprets Dyax’s decision to discontinue its Phase II evaluation or Kalbitor in ACE-inhibitor induced angioedema as not a negative, rather one that should prove to be smart financially. The shares have traded in a 52-week range of between $1.10 and $2.16.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.